Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Zhao, Weiwei ^a   Gong, Wei ^a   Wu, Nan ^a   Li, Yintao ^a   Ye, Kuanping ^a   Lu, Bin ^a   Zhang, Zhaoyun ^a   Qu, Shen ^b   Li, Yiming ^a   Yang, Yehong ^a   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Arterial stiffness; Brachial ankle pulse wave velocity (baPWV); Lipid profiles

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; CHOLESTEROL;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST HIP RATIO; BRACHIAL ANKLE PULSE WAVE VELOCITY; BRACHIAL ARTERY; MIDDLE AGED; ARTERY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTERIES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84898538387     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-37     Document Type: Article

References (28)

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, Circulation 2013 127 6 e245 10.1161/CIR.0b013e31828124ad 23239837
2. Lipid abnormalities and cardiovascular risk in the elderly. Milionis HJ, Elisaf MS, Mikhailidis DP, Curr Med Res Opin 2008 24 653 657 10.1185/030079908X273363 18218195 (Pubitemid 351428976)
3. Trends in risk factors for cardiovascular disease among Iranian adolescents: the Tehran Lipid and Glucose Study. Hosseini-Esfahani F, Mousavi Nasl Khameneh A, Mirmiran P, Ghanbarian A, Azizi F, J Epidemiol 2011 21 319 328 10.2188/jea.JE20100162 21804294
4. Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly. De Freitas EV, Brandão AA, Pozzan R, Magalhães ME, Fonseca F, Pizzi O, Campana E, Brandão AP, Arch Gerontol Geriatr 2011 52 217 222 10.1016/j.archger.2010. 03.022 20417975
5. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, Osaki R, Cockram CS, Chan JC, Diabetes Metab Res Rev 2005 21 183 188 10.1002/dmrr.497 15386811 (Pubitemid 40467665)
6. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Hung CS, Lin JW, Hsu CN, Chen HM, Tsai RY, Chien YF, Hwang JJ, Nutr Metab Cardiovasc Dis 2009 19 241 246 10.1016/j.numecd.2008.07.006 18815016
7. Serum high-density lipoprotein cholesterol and progression to arterial stiffness in middle-aged and elderly Chinese. Zhao WW, Yang YH, Lu B, Feng XC, He M, Yang ZH, Wen J, Zhang ZY, Yang Z, Li Q, Ye Z, Gong W, Hu RM, Nutr Metab Cardiovasc Dis 2013 23 973 979 10.1016/j.numecd.2012.08.001 23010609
8. Association of serum lipids with arterial stiffness in a population-based study in Beijing. Wang F, Ye P, Luo L, Xiao W, Qi L, Bian S, Wu H, Sheng L, Xiao T, Xu R, Eur J Clin Invest 2011 41 929 936 10.1111/j.1365-2362.2011.02481.x 21314825
9. Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. Holewijn S, Den Heijer M, Swinkels DW, Stalenhoef AF, De Graaf J, J Intern Med 2010 268 567 577 10.1111/j.1365-2796.2010.02277.x 21091808
10. Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E, Forziato C, Saitta F, Iardino MR, Di Carluccio C, Capaldo B, Diabetes Care 2012 35 158 162 10.2337/dc11-1456 22040842
11. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R, Cardiovasc Diabetol 2011 10 72 10.1186/1475-2840-10-72 21816063
12. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
13. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9- 200905050-00006 19414839
14. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, Lefevre ML, Mackenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E, JAMA 2014 311 507 520 10.1001/jama.2013.284427 24352797
15. Ethnic-specific criteria for the metabolic syndrome: evidence from China. Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D, Diabetes Care 2006 29 1414 1416 10.2337/dc06-0481 16732037 (Pubitemid 44125951)
16. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y, Hypertens Res 2002 25 359 364 10.1291/hypres.25.359 12135313 (Pubitemid 34752554)
17. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, Takeuchi H, Shimamoto K, Diabetes Care 2003 26 437 440 10.2337/diacare.26.2.437 12547876 (Pubitemid 36929069)
18. Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Brinkley TE, Nicklas BJ, Kanaya AM, Satterfield S, Lakatta EG, Simonsick EM, Sutton-Tyrrell K, Kritchevsky SB, Hypertension 2009 53 846 852 10.1161/HYPERTENSIONAHA.108. 127043 19332658
19. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Mattace-Raso FU, van der Cammen TJ, Hofman A, Van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC, Circulation 2006 113 657 663 10.1161/CIRCULATIONAHA.105.555235 16461838
20. Arterial stiffness, vascular disease, and risk of cardiovascular events. Cohn JN, Circulation 2006 113 601 603 10.1161/CIRCULATIONAHA.105.600866 16461830
21. Cholesterol, lipids and arterial stiffness. Wilkinson I, Cockcroft JR, Adv Cardiol 2007 44 261 277 17075215 (Pubitemid 44763916)
22. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM, J Intern Med 2013 273 595 601 10.1111/joim.12036 23331522
23. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM, Atherosclerosis 2011 219 596 602 10.1016/j.atherosclerosis.2011.08.001 21868017
24. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, INTERHEART study investigators, Lancet 2008 372 224 233 10.1016/S0140-6736(08)61076-4 18640459 (Pubitemid 351978112)
25. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM, J Am Coll Cardiol 2012 59 1521 1528 10.1016/j.jacc.2011.12.035 22516441
26. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Denke MA, Circulation 2005 112 3368 3370 10.1161/CIRCULATIONAHA.105.588178 16316961 (Pubitemid 43739548)
27. Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Eliasson B, Cederholm J, Eeg-Olofsson K, Svensson AM, Zethelius B, Gudbjörnsdottir S, National Diabetes Register, Diabetes Care 2011 34 2095 2100 10.2337/dc11-0209 21775750
28. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim KW, Kim JH, Int J Cardiol 2013 168 2678 2683 10.1016/j.ijcard.2013.03. 027 23545148